Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1898 1
1899 1
1915 1
1925 1
1926 1
1939 1
1940 1
1946 2
1947 1
1949 3
1969 1
1971 1
1972 1
1978 1
1979 3
1980 1
1981 4
1982 2
1983 5
1984 1
1985 6
1986 8
1987 10
1988 10
1989 7
1990 13
1991 13
1992 13
1993 6
1994 16
1995 19
1996 12
1997 20
1998 19
1999 20
2000 16
2001 22
2002 12
2003 25
2004 27
2005 24
2006 24
2007 19
2008 31
2009 36
2010 25
2011 26
2012 27
2013 38
2014 36
2015 30
2016 27
2017 31
2018 36
2019 37
2020 41
2021 37
2022 43
2023 41
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

848 results

Results by year

Filters applied: . Clear all
Page 1
Rickets.
Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor JM. Carpenter TO, et al. Nat Rev Dis Primers. 2017 Dec 21;3:17101. doi: 10.1038/nrdp.2017.101. Nat Rev Dis Primers. 2017. PMID: 29265106 Review.
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO. Jan de Beur SM, et al. Among authors: carpenter to. J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12. J Bone Miner Res. 2021. PMID: 33338281 Free PMC article. Clinical Trial.
Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia.
Linglart A, Imel EA, Whyte MP, Portale AA, Högler W, Boot AM, Padidela R, Van't Hoff W, Gottesman GS, Chen A, Skrinar A, Scott Roberts M, Carpenter TO. Linglart A, et al. Among authors: carpenter to. J Clin Endocrinol Metab. 2022 Feb 17;107(3):813-824. doi: 10.1210/clinem/dgab729. J Clin Endocrinol Metab. 2022. PMID: 34636899 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO; AXLES 1 Investigators. Insogna KL, et al. Among authors: carpenter to. J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26. J Bone Miner Res. 2018. PMID: 29947083 Free article. Clinical Trial.
Integrated host/microbe metagenomics enables accurate lower respiratory tract infection diagnosis in critically ill children.
Mick E, Tsitsiklis A, Kamm J, Kalantar KL, Caldera S, Lyden A, Tan M, Detweiler AM, Neff N, Osborne CM, Williamson KM, Soesanto V, Leroue M, Maddux AB, Simões EA, Carpenter TC, Wagner BD, DeRisi JL, Ambroggio L, Mourani PM, Langelier CR. Mick E, et al. Among authors: carpenter tc. J Clin Invest. 2023 Apr 3;133(7):e165904. doi: 10.1172/JCI165904. J Clin Invest. 2023. PMID: 37009900 Free PMC article.
The confluence of machine learning and multiscale simulations.
Bhatia H, Aydin F, Carpenter TS, Lightstone FC, Bremer PT, Ingólfsson HI, Nissley DV, Streitz FH. Bhatia H, et al. Among authors: carpenter ts. Curr Opin Struct Biol. 2023 Jun;80:102569. doi: 10.1016/j.sbi.2023.102569. Epub 2023 Mar 24. Curr Opin Struct Biol. 2023. PMID: 36966691 Review.
848 results